Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 4Phase 1 3Phase 1/2 2Phase 2/3 1

Status

Recruiting 2Completed 2

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 27Lymphoid 21Sarcoma 4CNS 2

Conditions

Sarcoma 3Leiomyosarcoma 3Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Liposarcoma 1

Interventions

Doxorubicin 40Radiotherapy 30Ifosfamide 28Vincristine 27Cyclophosphamide 24Imatinib Mesylate 20Etoposide 20Dactinomycin 14Radiation 13Filgrastim 11Temozolomide 9Sunitinib 9Trabectedin 8Methotrexate 8Specimen Handling 7Magnetic Resonance Spectroscopy 6Granulocyte Colony-Stimulating Factor 6Chemotherapy, Adjuvant 6pazopanib 5nilotinib 5Zoledronic Acid 5Neoadjuvant Therapy 5Irinotecan 5Cisplatin 5Carboplatin 5X-Rays 4Vinorelbine 4Topotecan 4Surgical Procedures, Operative 4Procarbazine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Dacarbazine × Sarcoma × Clear all
NCT03016819 2026-02-25

APROMISS

Advenchen Laboratories, LLC

Phase 3 Recruiting
325 enrolled
Sarcoma

Leiomyosarcoma, Sarcoma, Sarcoma, Synovial, Sarcoma, Alveolar Soft Part

NCT03805022 2025-10-02

CIRSARC

Institut Bergonié

Phase 3 Recruiting
351 enrolled
Sarcoma

Sarcoma

NCT01692678 2018-07-11

A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Xian-Janssen Pharmaceutical Ltd.

Phase 3 Completed
16 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

NCT01343277 2016-08-26

A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma

Janssen Research & Development, LLC

Phase 3 Completed
579 enrolled 13 charts
Sarcoma

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡